• Home
  • Shop
  • About
  • FAQ
  • Contact
  • Compare Peptides
  • Wholesale
  • Peptide Research Encyclopedia & Glossary

    Research Disclaimer: This glossary is provided for educational and research reference purposes only. All terminology and descriptions relate to preclinical and clinical research contexts. Iron Peak Peptides products are sold exclusively for laboratory and scientific research use. This content does not constitute medical advice.

    Introduction

    Peptide science sits at one of the most dynamic intersections of modern biochemistry, pharmacology, and molecular biology. From growth-factor signaling to neuroprotection and metabolic regulation, peptides are the subject of thousands of active research programs worldwide. Yet the vocabulary surrounding these biomolecules can be formidableҀ”spanning organic chemistry, analytical instrumentation, regulatory affairs, and laboratory best practices.

    The Peptide Research Encyclopedia & Glossary was created by Iron Peak Peptides as a single-source reference for researchers, graduate students, and laboratory professionals who work with synthetic peptides. Every entry below is written in a research-only context: technical definitions are paired with plain-language explanations so that readers at every experience level can benefit.

    Use the navigation headings to jump between sections, or simply scroll through the alphabetical core-science terms, peptide category overviews, methodology vocabulary, regulatory language, and storage-and-handling guidance that follow. A comprehensive abbreviations table and peer-reviewed citation list are provided at the end.

    Core Peptide Science Terms (AҀ“Z)

    The following terms form the foundational vocabulary of peptide research. Each entry includes a formal definition followed by a researcher-friendly explanation.

    Amino Acid

    Technical definition: An organic molecule containing both an amino group (Γ’ΒˆΒ’NH҂‚) and a carboxyl group (Γ’ΒˆΒ’COOH), along with a side chain (R group) specific to each amino acid. Twenty standard (canonical) amino acids serve as the monomeric building blocks of peptides and proteins (Nelson & Cox, 2017).

    In plain language: Think of amino acids as the individual letters of an alphabet. Strung together in specific sequences, they spell out unique peptides and proteins, each with a distinct three-dimensional shape and biological function.

    Agonist

    Technical definition: A molecule that binds to a receptor and activates it, triggering an intracellular signaling cascade. In peptide research, agonists are studied for their ability to mimic endogenous ligands at target receptors (Kenakin, 2019).

    In plain language: An agonist turns a biological switch on. When a synthetic peptide acts as an agonist, it reproducesҀ”or amplifiesҀ”the effect of the body’s own signaling molecule at a given receptor.

    Antagonist

    Technical definition: A molecule that binds to a receptor without activating it, thereby blocking the natural ligand from binding. Peptide antagonists are valuable research tools for studying receptor function (Kenakin, 2019).

    In plain language: The opposite of an agonist: an antagonist occupies the receptor’s binding site but keeps the switch off, preventing the natural signal from getting through.

    Bioavailability

    Technical definition: The fraction of an administered compound that reaches systemic circulation in an unchanged, pharmacologically active form. Bioavailability is typically expressed as a percentage relative to intravenous administration, which is defined as 100 % (Shargel et al., 2012).

    Bioconjugation

    Technical definition: The chemical strategy of covalently attaching a peptide to another moleculeҀ”such as polyethylene glycol (PEG), a fatty acid, or an antibodyҀ”to alter its pharmacokinetic or pharmacodynamic profile (Hermanson, 2013).

    In plain language: Bioconjugation is like adding a protective shell or an address label to a peptide, extending its half-life or directing it to a specific tissue.

    C-Terminus

    Technical definition: The end of a peptide chain that carries a free carboxyl group (Γ’ΒˆΒ’COOH). By convention, peptide sequences are written from the N-terminus (left) to the C-terminus (right) (Berg et al., 2015).

    In plain language: If you read a peptide like a sentence, the C-terminus is the period at the endҀ”the last amino acid in the chain.

    Cyclization

    Technical definition: The formation of a ring structure within a peptide, achieved by creating a bond between two residues (head-to-tail, side-chain-to-side-chain, or disulfide bridge). Cyclization often enhances metabolic stability and receptor selectivity (White & Yudin, 2011).

    In plain language: Bending a linear peptide into a circle makes it harder for enzymes to chew apart, giving researchers a more durable tool for in vivo experiments.

    Disulfide Bond

    Technical definition: A covalent bond formed between the sulfur atoms of two cysteine residues (Γ’ΒˆΒ’SΓ’ΒˆΒ’SΓ’ΒˆΒ’). Disulfide bonds stabilize the three-dimensional structure of many peptides and proteins (Creighton, 1997).

    In plain language: Two cysteine residues act like molecular staples, locking parts of the peptide together and preventing it from unfolding.

    Endogenous

    Technical definition: Originating from within the organism. An endogenous peptide is one naturally produced by the body, such as insulin or growth hormoneҀ“releasing hormone (GHRH).

    In plain language: If a peptide is endogenous, the body already makes it. Synthetic analogs of endogenous peptides are a major focus of research because they can be engineered for improved potency or stability.

    Exogenous

    Technical definition: Originating from outside the organism. Exogenous peptides are synthetically produced and introduced into a biological system for research purposes.

    In plain language: The complement of endogenous. When a researcher adds a synthetic peptide to a cell culture or administers it to a research model, that peptide is exogenous.

    Half-Life (t½)

    Technical definition: The time required for the concentration of a substance in a defined compartment (e.g., plasma) to decrease by 50 %.

    In plain language: Half-life tells a researcher how quickly a peptide disappears from the system.

    Ligand

    Technical definition: Any molecule that binds specifically to a receptor or other macromolecule. Peptide ligands are widely used in research to probe receptor pharmacology (Kenakin, 2019).

    In plain language: A ligand is the ‘key’ that fits into a receptor ‘lock.’ Researchers use peptide ligands to investigate which cellular doors can be openedҀ”or closed.

    Lyophilization

    Technical definition: A dehydration process (freeze-drying) in which a peptide solution is frozen and then subjected to reduced pressure so that the ice sublimates directly to vapor. Lyophilization yields a stable, dry powder suitable for long-term storage (Franks, 2007).

    In plain language: Freeze-drying removes water without heat, preserving the peptide’s structure. The resulting fluffy white powder is what researchers receive in most peptide vials. See also the Storage & Handling section.

    Molecular Weight (MW)

    Technical definition: The sum of the atomic weights of all atoms in a molecule, expressed in Daltons (Da) or grams per mole (g/mol). Peptides typically range from ~500 Da (pentapeptide) to ~10,000 Da, above which they are conventionally classified as small proteins (IUPAC, 1997).

    In plain language: Molecular weight is the peptide’s ‘size tag.’ It determines how the peptide behaves during purification (HPLC, mass spectrometry) and can influence bioavailability.

    N-Terminus

    Technical definition: The end of a peptide chain bearing a free amino group (Γ’ΒˆΒ’NH҂‚). Peptide sequences are written starting from the N-terminus (Berg et al., 2015).

    In plain language: The beginning of the peptide sentence. The first amino acid listed in a sequence is always the N-terminal residue.

    Peptide

    Technical definition: A short chain of amino acids linked by peptide (amide) bonds. IUPAC defines peptides as chains of approximately 2Ҁ“50 amino acid residues; longer chains are generally termed proteins (IUPAC, 1997).

    In plain language: Peptides are essentially small proteins. Their compact size allows researchers to design highly specific molecules that target individual receptors or biological pathways.

    Peptide Bond

    Technical definition: The covalent amide bond (Γ’ΒˆΒ’COΓ’ΒˆΒ’NHΓ’ΒˆΒ’) formed by a condensation reaction between the α-carboxyl group of one amino acid and the α-amino group of the next, releasing one molecule of water (Nelson & Cox, 2017).

    In plain language: The peptide bond is the glue that holds amino acids together in a chain. Every time two amino acids join, a water molecule is releasedҀ”a reaction repeated hundreds of thousands of times in living cells every second.

    PEGylation

    Technical definition: The covalent attachment of one or more polyethylene glycol (PEG) polymers to a peptide or protein. PEGylation increases hydrodynamic radius, reduces renal clearance, and can shield the molecule from proteolytic degradation (Veronese & Pasut, 2005).

    In plain language: Wrapping a peptide in a PEG ‘blanket’ makes it bigger and slipperierҀ”harder for enzymes to degrade and slower for the kidneys to filter out, effectively extending its half-life.

    Post-Translational Modification (PTM)

    Technical definition: Chemical modifications made to a protein or peptide after its synthesis by the ribosome. Common PTMs include phosphorylation, acetylation, glycosylation, and amidation (Walsh et al., 2005).

    In plain language: After a peptide is built, the cell may add chemical ‘accessories’ that change its behaviorҀ”switching it on, off, or redirecting it to a different cellular compartment.

    Proteolysis

    Technical definition: The enzymatic hydrolysis of peptide bonds by proteases. Proteolysis is a major barrier to peptide stability in vivo and a key consideration in research peptide design (Drag & Salvesen, 2010).

    In plain language: Enzymes in blood and tissues constantly snip peptide bonds. Researchers counter proteolysis through cyclization, D-amino acid substitution, and other stabilization strategies.

    Receptor

    Technical definition: A proteinҀ”usually located on the cell surface or within the cytoplasmҀ”that binds a specific ligand and transduces a signal into the cell. G-protein-coupled receptors (GPCRs) are the most common targets for peptide ligands (Rosenbaum et al., 2009).

    In plain language: Receptors are molecular antennae. When a peptide binds to one, it triggers a chain of events inside the cellҀ”like pressing a button on a control panel.

    Selectivity

    Technical definition: The degree to which a peptide binds to its intended target receptor relative to other receptors. High selectivity minimizes off-target effects in research models (Kenakin, 2019).

    In plain language: A highly selective peptide is like a key that only opens one door. Low selectivity means the key fits many locks, which can complicate data interpretation.

    Sequence

    Technical definition: The specific linear order of amino acid residues in a peptide, read from N-terminus to C-terminus and typically expressed using one- or three-letter amino acid codes (e.g., GHRP-6: His-D-Trp-Ala-Trp-D-Phe-Lys-NH҂‚).

    In plain language: A peptide’s sequence is its ‘recipe.’ Even a single amino acid change can dramatically alter biological activityҀ”making sequence accuracy paramount in research supply.

    Solid-Phase Peptide Synthesis (SPPS)

    Technical definition: A method developed by R. Bruce Merrifield in which amino acids are sequentially coupled to a growing peptide chain that is anchored to an insoluble resin support. SPPS is the dominant method for manufacturing research-grade peptides (Merrifield, 1963).

    In plain language: SPPS builds a peptide one amino acid at a time on a tiny bead. After the full chain is assembled, the peptide is cleaved from the bead, purified, and lyophilized for distribution.

    Substrate

    Technical definition: A molecule upon which an enzyme acts. In peptide research, substrates are used in bioassays to measure enzymatic activity or to screen peptide inhibitors.

    In plain language: If an enzyme is a pair of scissors, the substrate is the paper it cuts. Researchers measure how well a peptide blocks (or accelerates) that cutting action.

    Peptide Categories in Research

    Peptides studied in modern research programs span a wide range of biological targets. Below are the principal categories, with representative examples and links to relevant Iron Peak Peptides research products.

    Growth Hormone Secretagogues (GHS)

    Growth hormone secretagogues are a class of compounds that stimulate the secretion of growth hormone (GH) from the anterior pituitary gland. The term encompasses both peptidyl and non-peptidyl molecules that act primarily through the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor (Kojima et al., 1999). GHS research is central to studies of somatotropic axis regulation, body composition, and age-related GH decline.

    Key research compounds in this category include MK-677 (Ibutamoren), a non-peptide GHS that has been studied for its oral bioavailability and sustained GH-releasing effects. MK-677 activates GHS-R1a and has been investigated in clinical research for its effects on GH pulsatility, insulin-like growth factor 1 (IGF-1) levels, lean body mass, and sleep quality (Nass et al., 2008). Iron Peak Peptides offers MK-677 (25 mg) for qualified research use.

    Growth Hormone Releasing Peptides (GHRP)

    Growth Hormone Releasing Peptides (GHRPs) are synthetic hexapeptide or smaller analogs that stimulate GH release by binding the GHS-R1a receptor. GHRPs studied in the literature include GHRP-2, GHRP-6, and hexarelin.

    Research has demonstrated that GHRPs produce synergistic GH release when administered alongside GHRH analogs, making combination protocols a common experimental design. GHRPs also display secondary activities including effects on appetite, cortisol release, and cardiac function, all of which are active areas of preclinical investigation.

    Growth Hormone Releasing Hormones (GHRH)

    GHRH analogs are synthetic peptides based on the 44-amino-acid endogenous growth hormoneҀ“releasing hormone (GHRH(1-44)-NH҂‚). They bind the GHRH receptor (GHRH-R) on somatotroph cells in the anterior pituitary, activating a cAMP-dependent pathway that promotes GH transcription and secretion (Mayo et al., 1995). Research-grade GHRH analogs include Sermorelin (GHRH(1-29)-NH҂‚), Modified GRF(1-29) (often called “Mod-GRF”), and CJC-1295.

    CJC-1295 with DAC (Drug Affinity Complex) is a GHRH analog conjugated to a lysine-linked maleimidopropionic acid linker that binds serum albumin in vivo, dramatically extending its half-life from minutes to several days (Teichman et al., 2006). This makes it a valuable tool for studying sustained GH elevation in animal models. Iron Peak Peptides supplies CJC-1295 DAC (5 mg) for research applications.

    Ipamorelin is a selective pentapeptide GHS that is frequently paired with GHRH analogs in research protocols. It is notable for its selectivityҀ”producing GH release without significantly affecting cortisol or prolactin levels in preclinical models (Raun et al., 1998). Ipamorelin (5 mg) is available from Iron Peak Peptides.

    BPC Peptides (Body Protection Compounds)

    Body Protection Compound-157 (BPC-157) is a 15-amino-acid peptide derived from a protein found in human gastric juice. It has been extensively studied in animal models for its effects on wound healing, angiogenesis, and tissue repair across multiple organ systemsҀ”including musculoskeletal, gastrointestinal, and neurological tissues (Sikiric et al., 2018). BPC-157 research has reported activity via the FAK-paxillin and JAK-2/STAT-3 signaling pathways, and its interaction with the nitric oxide (NO) system is an active area of investigation.

    Iron Peak Peptides offers BPC-157 (10 mg) for laboratory research.

    Thymosin Peptides

    The thymosin family of peptides was originally isolated from thymic tissue and is involved in immune modulation, tissue repair, and cell migration. Two members are of particular research interest:

    • Thymosin Beta-4 (Tβ4 / TB-500): A 43-amino-acid peptide that is the primary G-actin-sequestering molecule in eukaryotic cells. Research has focused on its roles in wound healing, anti-inflammation, angiogenesis, and hair follicle stem cell migration (Goldstein et al., 2012). TB-500 (10 mg) is available from Iron Peak Peptides.
    • Thymosin Alpha-1 (Tα1): A 28-amino-acid peptide studied for its immunomodulatory properties. Tα1 has been investigated in research models for enhancing dendritic cell maturation, T-cell function, and vaccine response (Tuthill et al., 2020).

    Melanocortin Peptides

    Melanocortin peptides are ligands of the melanocortin receptor family (MC1RҀ“MC5R), a group of GPCRs involved in pigmentation, energy homeostasis, inflammation, and sexual function (Gantz & Fong, 2003). Alpha-melanocyte-stimulating hormone (α-MSH) is the principal endogenous melanocortin.

    PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist originally derived from the superpotent analog Melanotan II. PT-141 has been studied for its activation of MC3R and MC4R in preclinical models investigating sexual behavior and arousal pathways (Molinoff et al., 2003). Iron Peak Peptides provides PT-141 (10 mg) for qualified researchers.

    GLP-1 Receptor Agonists

    Glucagon-like peptide-1 (GLP-1) receptor agonists are among the most intensively studied peptide classes of the past two decades. GLP-1 is an incretin hormone secreted by intestinal L-cells that potentiates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and modulates central appetite circuits (Drucker, 2018).

    Semaglutide is a long-acting GLP-1 receptor agonist featuring a fatty di-acid side chain that promotes albumin binding and resistance to DPP-4 cleavage, yielding a half-life of approximately 7 days in human pharmacokinetic studies (Lau et al., 2015). Research continues into semaglutide’s effects on glycemic control, body weight, cardiovascular risk markers, and neuroinflammation. Semaglutide (5 mg) is available from Iron Peak Peptides.

    Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. Its dual-incretin mechanism has been the subject of large-scale clinical research programs evaluating metabolic endpoints (Frías et al., 2021). Iron Peak Peptides offers Tirzepatide (30 mg) for research purposes.

    Neuropeptides

    Neuropeptides are signaling molecules produced and released by neurons that modulate synaptic transmission, neuroendocrine function, and behavior. Examples include substance P, neuropeptide Y, oxytocin, and enkephalins (Hâkfelt et al., 2000).

    Selank is a synthetic heptapeptide analog of the endogenous immunomodulatory peptide tuftsin, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences. It has been investigated in animal models for anxiolytic-like effects, cognitive modulation, and influence on brain-derived neurotrophic factor (BDNF) expression (Zozulya et al., 2001). Selank (10 mg) is available from Iron Peak Peptides for preclinical research.

    NAD+ (Nicotinamide Adenine Dinucleotide), while not a peptide per se, is a coenzyme frequently studied alongside peptide interventions in longevity and neuroprotection research. NAD+ is essential for sirtuin activity, mitochondrial function, and DNA repair (Verdin, 2015). Iron Peak Peptides offers NAD+ (500 mg) for research use.

    Cellular-Aging & Longevity Peptides

    A growing body of research focuses on peptides that may influence hallmarks of aging such as telomere attrition, mitochondrial dysfunction, cellular senescence, and extracellular matrix degradation (López-Otín et al., 2013).

    Epithalon (Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) studied for its effects on telomerase activity. Research by Khavinson and colleagues reported that Epithalon activated telomerase catalytic subunit (hTERT) expression in human somatic cells, suggesting a role in telomere maintenance pathways (Khavinson et al., 2003). Epithalon (50 mg) is available from Iron Peak Peptides.

    GHK-Cu (Copper Peptide) is a naturally occurring tripeptideҀ“copper complex (Gly-His-Lys·Cu²ҁº) found in human plasma, saliva, and urine. GHK-Cu has been studied for its ability to promote collagen synthesis, attract immune cells, exhibit antioxidant effects, and stimulate dermal remodeling in vitro and in animal wound models (Pickart et al., 2015). GHK-Cu (200 mg) is offered by Iron Peak Peptides for research.

    Research Methodology Terms

    Understanding the methods behind peptide research is as important as knowing the peptides themselves. The following terms appear frequently in published literature and laboratory protocols.

    In Vitro

    Latin for ‘in glass.’ Refers to experiments conducted outside a living organism, typically in cell cultures, tissue preparations, or biochemical assays (Freshney, 2016). In vitro studies allow researchers to isolate specific variablesҀ”such as a peptide’s binding affinity or cytotoxicityҀ”without the complexity of whole-organism physiology.

    In Vivo

    Latin for ‘in the living.’ Refers to studies performed within a living organism, usually an animal model. In vivo research is essential for evaluating pharmacokinetics, biodistribution, and systemic effects of peptides before any consideration of clinical translation (Barré-Sinoussi & Montagutelli, 2015).

    Ex Vivo

    Experiments conducted on tissue or cells removed from an organism and studied under controlled external conditions. Ex vivo assays bridge the gap between in vitro simplicity and in vivo complexity.

    Bioassay

    A quantitative analytical method that measures the biological activity of a substance (e.g., a peptide) by observing its effect on living cells or organisms. Common peptide bioassays include cell proliferation assays, receptor-binding assays, and reporter-gene assays (Dougherty & Bhatt, 2012).

    IC҂…Ò‚€ and EC҂…Ò‚€

    IC҂…Ò‚€ (half-maximal inhibitory concentration): The concentration of a peptide required to inhibit a biological process by 50 %. EC҂…Ò‚€ (half-maximal effective concentration): The concentration that produces 50 % of the maximal response. Both are fundamental measures of peptide potency in pharmacological research.

    Pharmacokinetics (PK)

    The study of how a peptide is absorbed, distributed, metabolized, and excreted (ADME) over time.

    Pharmacodynamics (PD)

    The study of the biochemical and physiological effects of a peptide on the body and the mechanisms by which those effects occur. PD is often characterized alongside PK in integrated PK/PD models.

    Lyophilization (Freeze-Drying)

    A low-temperature dehydration process used to convert peptide solutions into stable dry powders. The peptide solution is first frozen, then placed under vacuum so that ice sublimates directly to vapor without passing through a liquid phase. Lyophilization preserves peptide integrity during storage and shipping (Franks, 2007). Most research-grade peptides are supplied in lyophilized form.

    HPLC (High-Performance Liquid Chromatography)

    An analytical and preparative technique that separates components of a mixture based on their interactions with a stationary phase and a mobile phase. Reverse-phase HPLC (RP-HPLC) is the standard method for assessing the purity of synthetic peptides; a purity of Γ’Β‰Β₯98 % is typical for research-grade material (Aguilar, 2004).

    Mass Spectrometry (MS)

    An analytical technique that measures the mass-to-charge ratio (m/z) of ions. In peptide research, electrospray ionization mass spectrometry (ESI-MS) and matrix-assisted laser desorption/ionization (MALDI) are used to confirm molecular identity, detect post-translational modifications, and verify synthetic accuracy.

    Enzyme-Linked Immunosorbent Assay (ELISA)

    A plate-based assay that uses antibodies and colorimetric or fluorescent detection to quantify peptides, proteins, or hormones in biological samples. Sandwich ELISAs are commonly used to measure peptide concentrations in serum or cell culture supernatants.

    Western Blot

    A technique used to detect and semi-quantify specific proteins or peptides in a complex mixture. Proteins are separated by gel electrophoresis, transferred to a membrane, and probed with specific antibodies.

    Regulatory & Compliance Terms

    Navigating the regulatory landscape around peptide research requires familiarity with the following terms and standards.

    For Research Use Only (RUO)

    For Research Use Only (RUO): A designation indicating that a product is intended solely for laboratory research and is not approved for human or veterinary therapeutic use. All Iron Peak Peptides products carry this designation. RUO products are exempt from certain regulatory requirements applicable to drugs or medical devices but must be handled in accordance with laboratory safety standards.

    FDA (U.S. Food and Drug Administration)

    FDA (U.S. Food and Drug Administration): The federal agency responsible for regulating drugs, biologics, medical devices, and food safety in the United States. Synthetic peptides intended for therapeutic use in humans must undergo an Investigational New Drug (IND) application process and clinical trials before FDA approval. Research-use peptides sold by suppliers like Iron Peak Peptides are not subject to IND requirements.

    GMP (Good Manufacturing Practice)

    GMP (Good Manufacturing Practice): A set of guidelines enforced by regulatory agencies (e.g., FDA, EMA) that ensure products are consistently produced and controlled according to quality standards. GMP covers facility design, equipment maintenance, personnel training, documentation, and quality control testing. While research-grade peptides are not required to be GMP-manufactured, many suppliers follow GMP-like quality systems.

    available lot documentation (CoA)

    available lot documentation (CoA): A document issued by the manufacturer or an independent laboratory that reports the results of quality-control testing for a specific batch of product. A typical peptide CoA includes HPLC purity, mass spectrometry confirmation, appearance, peptide content, and endotoxin levels. Iron Peak Peptides provides a CoA with every product lot.

    Third-Party Testing

    Third-Party Testing: Independent analytical verification performed by a laboratory that is not affiliated with the manufacturer. Third-party testing enhances confidence in product identity, purity, and potency and is considered a best practice in the research peptide industry.

    DEA Scheduling

    DEA Scheduling: The classification system used by the U.S. Drug Enforcement Administration to categorize controlled substances based on their potential for abuse and accepted medical use. Most research peptides are not DEA-scheduled; however, researchers should verify the regulatory status of specific compounds in their jurisdiction.

    IRB (Institutional Review Board)

    IRB (Institutional Review Board): An ethics committee that reviews and monitors research involving human subjects. Any clinical study involving peptide administration to humans requires IRB approval under federal regulations (21 CFR Part 56).

    IACUC (Institutional Animal Care and Use Committee)

    IACUC (Institutional Animal Care and Use Committee): A committee mandated by the Animal Welfare Act that oversees and evaluates animal research protocols to ensure ethical treatment and compliance with federal regulations.

    Storage & Handling Terms

    Proper storage and handling of research peptides are essential for maintaining integrity and ensuring reproducible experimental results.

    Bacteriostatic Water (BAC Water)

    Bacteriostatic Water (BAC Water): Sterile water containing 0.9 % benzyl alcohol as a preservative, which inhibits microbial growth.

    Lyophilized Powder

    Lyophilized Powder: The dry, porous solid obtained after freeze-drying a peptide solution. Lyophilized peptides are significantly more stable than their dissolved counterparts; when stored sealed at Γ’ΒˆΒ’20 °C, many lyophilized peptides retain activity for years.

    Cold Chain

    Cold Chain: The temperature-controlled supply chain required to maintain product integrity during shipping and storage. Research peptides typically require 2Ҁ“8 °C (refrigerated) or Γ’ΒˆΒ’20 °C (frozen) conditions. Iron Peak Peptides ships with appropriate cold-chain packaging to protect products during transit.

    Desiccant

    Desiccant: A hygroscopic substance (e.g., silica gel) placed inside packaging to absorb moisture and protect lyophilized products from humidity-induced degradation. Researchers should keep desiccant packs in peptide storage containers.

    Aliquoting

    Aliquoting minimizes repeated freezeҀ“thaw cycles, which can degrade peptides through ice-crystal formation and interfacial stress.

    FreezeҀ“Thaw Cycle

    FreezeҀ“Thaw Cycle: The process of freezing a peptide solution and then thawing it for use. Each cycle can introduce physical stress (ice crystal formation) and chemical degradation (oxidation at the airҀ“liquid interface).

    Light Protection

    Light Protection: Many peptidesҀ”especially those containing tryptophan, tyrosine, or metal-ion complexesҀ”are susceptible to photodegradation.

    Peptide Content (Net Peptide Weight)

    Peptide Content (Net Peptide Weight): The actual mass of bioactive peptide in a vial, expressed as a percentage of the gross weight. Lyophilized peptides contain residual moisture, counter-ions (e.g., acetate, TFA salts), and water of hydration. Typical peptide content ranges from 60Ҁ“85 % of gross weight. Researchers should consult the CoA to calculate accurate molar concentrations.

    Common Abbreviations in Peptide Research

    The table below compiles abbreviations frequently encountered in peptide literature, product labels, and available lot documentation.

    AbbreviationFull Term
    AAAmino Acid
    ADMEAbsorption, Distribution, Metabolism, Excretion
    AUCArea Under the Curve
    BAC WaterBacteriostatic Water
    BPCBody Protection Compound
    CoAavailable lot documentation
    CJC-1295Modified GHRH analog (with or without DAC)
    DACDrug Affinity Complex
    Da / kDaDalton / Kilodalton (units of molecular weight)
    DPP-4Dipeptidyl Peptidase-4
    EC҂…Ò‚€Half-Maximal Effective Concentration
    ELISAEnzyme-Linked Immunosorbent Assay
    ESI-MSElectrospray Ionization Mass Spectrometry
    FDAU.S. Food and Drug Administration
    GHGrowth Hormone
    GHK-CuGlycyl-L-Histidyl-L-Lysine Copper Complex
    GHRHGrowth Hormone Releasing Hormone
    GHRPGrowth Hormone Releasing Peptide
    GHSGrowth Hormone Secretagogue
    GIPGlucose-Dependent Insulinotropic Polypeptide
    GLP-1Glucagon-Like Peptide-1
    GMPGood Manufacturing Practice
    GPCRG-Protein-Coupled Receptor
    HPLCHigh-Performance Liquid Chromatography
    IC҂…Ò‚€Half-Maximal Inhibitory Concentration
    IGF-1Insulin-Like Growth Factor 1
    IUPACInternational Union of Pure and Applied Chemistry
    IVIntravenous
    MALDIMatrix-Assisted Laser Desorption/Ionization
    MC1RҀ“MC5RMelanocortin Receptors 1 through 5
    MSMass Spectrometry
    MWMolecular Weight
    NAD+Nicotinamide Adenine Dinucleotide
    NONitric Oxide
    PDPharmacodynamics
    PEGPolyethylene Glycol
    PKPharmacokinetics
    PTMPost-Translational Modification
    RP-HPLCReverse-Phase High-Performance Liquid Chromatography
    RUOResearch Use Only
    SPPSSolid-Phase Peptide Synthesis
    TB-500Thymosin Beta-4 fragment (research designation)
    TFATrifluoroacetic Acid (common counter-ion in peptide synthesis)
    t½Half-Life
    UVUltraviolet
    α-MSHAlpha-Melanocyte-Stimulating Hormone

    References & Citations

    The following peer-reviewed and authoritative sources were used in the preparation of this glossary.

    1. Aguilar, M.-I. (2004). HPLC of Peptides and Proteins: Methods and Protocols. Methods in Molecular Biology, vol. 251. Humana Press.
    2. Barré-Sinoussi, F., & Montagutelli, X. (2015). Animal models are essential to biological research: issues and perspectives. Future Science OA, 1(4), FSO63.
    3. Berg, J. M., Tymoczko, J. L., & Stryer, L. (2015). Biochemistry (8th ed.). W. H. Freeman.
    4. Bowers, C. Y. (1998). Growth hormone-releasing peptide (GHRP). Cellular and Molecular Life Sciences, 54(12), 1316Ҁ“1329.
    5. Creighton, T. E. (1997). Protein Structure: A Practical Approach (2nd ed.). Oxford University Press.
    6. Drag, M., & Salvesen, G. S. (2010). Emerging principles in protease-based drug discovery. Nature Reviews Drug Discovery, 9(9), 690Ҁ“701.
    7. Drucker, D. J. (2018). Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metabolism, 27(4), 740Ҁ“756.
    8. Franks, F. (2007). Freeze-Drying of Pharmaceuticals and Biopharmaceuticals. Royal Society of Chemistry.
    9. Frías, J. P., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503Ҁ“515.
    10. Gantz, I., & Fong, T. M. (2003). The melanocortin system. American Journal of PhysiologyҀ“Endocrinology and Metabolism, 284(3), E468Ҁ“E474.
    11. Goldstein, A. L., Hannappel, E., Sosne, G., & Kleinman, H. K. (2012). Thymosin β4: a multi-functional regenerative peptide. Expert Opinion on Biological Therapy, 12(sup1), S37Ҁ“S51.
    12. Hermanson, G. T. (2013). Bioconjugate Techniques (3rd ed.). Academic Press.
    13. Hâkfelt, T., Broberger, C., Xu, Z.-Q. D., Sergeyev, V., Ubink, R., & Diez, M. (2000). NeuropeptidesҀ”an overview. Neuropharmacology, 39(8), 1337Ҁ“1356.
    14. Kenakin, T. P. (2019). A Pharmacology Primer: Techniques for More Effective and Strategic Drug Discovery (5th ed.). Academic Press.
    15. Khavinson, V. K., Bondarev, I. E., & Butyugov, A. A. (2003). Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine, 135(6), 590Ҁ“592.
    16. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999). Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402(6762), 656Ҁ“660.
    17. Lau, J., et al. (2015). Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. Journal of Medicinal Chemistry, 58(18), 7370Ҁ“7380.
    18. López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013). The hallmarks of aging. Cell, 153(6), 1194Ҁ“1217.
    19. Mayo, K. E., et al. (1995). Regulation of the pituitary somatotroph cell by GHRH and its receptor. Recent Progress in Hormone Research, 50, 35Ҁ“73.
    20. Merrifield, R. B. (1963). Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. Journal of the American Chemical Society, 85(14), 2149Ҁ“2154.
    21. Molinoff, P. B., Shadiack, A. M., Earle, D., Diamond, L. E., & Quon, C. Y. (2003). PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Annals of the New York Academy of Sciences, 994(1), 96Ҁ“102.
    22. Nass, R., et al. (2008). Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults. Annals of Internal Medicine, 149(9), 601Ҁ“611.
    23. Nelson, D. L., & Cox, M. M. (2017). Lehninger Principles of Biochemistry (7th ed.). W. H. Freeman.
    24. Pickart, L., Vasquez-Soltero, J. M., & Margolina, A. (2015). GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Research International, 2015, 648108.
    25. Raun, K., et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology, 139(5), 552Ҁ“561.
    26. Rosenbaum, D. M., Rasmussen, S. G. F., & Kobilka, B. K. (2009). The structure and function of G-protein-coupled receptors. Nature, 459(7245), 356Ҁ“363.
    27. Rowland, M., & Tozer, T. N. (2011). Clinical Pharmacokinetics and Pharmacodynamics (4th ed.). Lippincott Williams & Wilkins.
    28. Shargel, L., Yu, A. B. C., & Wu-Pong, S. (2012). Applied Biopharmaceutics & Pharmacokinetics (7th ed.). McGraw-Hill.
    29. Sikiric, P., et al. (2018). Brain-gut axis and pentadecapeptide BPC 157: theoretical and practical implications. Current Neuropharmacology, 16(5), 566Ҁ“583.
    30. Teichman, S. L., et al. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology & Metabolism, 91(3), 799Ҁ“805.
    31. Tuthill, C., Rios, I., & McBeath, R. (2020). Thymosin alpha 1: past clinical experience and future promise. Annals of the New York Academy of Sciences, 1470(1), 5Ҁ“13.
    32. Verdin, E. (2015). NADҁº in aging, metabolism, and neurodegeneration. Science, 350(6265), 1208Ҁ“1213.
    33. Veronese, F. M., & Pasut, G. (2005). PEGylation, successful approach to drug delivery. Drug Discovery Today, 10(21), 1451Ҁ“1458.
    34. Walsh, C. T., Garneau-Tsodikova, S., & Gatto, G. J. (2005). Protein posttranslational modifications: the chemistry of proteome diversifications. Angewandte Chemie International Edition, 44(45), 7342Ҁ“7372.
    35. White, C. J., & Yudin, A. K. (2011). Contemporary strategies for peptide macrocyclization. Nature Chemistry, 3(7), 509Ҁ“524.
    36. Zozulya, A. A., Gabaeva, M. V., Sokolov, O. Y., Surkina, I. D., & Kost, N. V. (2001). Personality, coping style, and constitutional neurohumoral characteristics. European Neuropsychopharmacology, 11(Suppl 3), S310Ҁ“S311.
    Research Disclaimer: This glossary is provided for educational and research reference purposes only. All terminology and descriptions relate to preclinical and clinical research contexts. Iron Peak Peptides products are sold exclusively for laboratory and scientific research use. This content does not constitute medical advice.